Home NDC 31722-557 Abacavir
Product NDC 31722-557
11-digit product format 317220557
Labeler code 31722
Product ID 31722-557_2b451c79-7df8-d0f9-e063-6294a90a5fcf
Type HUMAN PRESCRIPTION DRUG
Nonproprietary name Abacavir
Dosage form TABLET
Route ORAL
Labeler Camber Pharmaceuticals, Inc.
Application ANDA091560
Marketing category ANDA
Marketing start 2021-04-01
Substance ABACAVIR SULFATE
Active strength 300 mg/1
Pharmacologic classes Cytochrome P450 1A1 Inhibitors [MoA], Human Immunodeficiency Virus Nucleoside Analog Reverse Transcriptase Inhibitor [EPC], Nucleoside Reverse Transcriptase Inhibitors [MoA]
NDC exclude flag No
Listing certified through 2026-12-31
Current FDA listing Yes Source provenance: Browse the complete Orange Book source catalog · source snapshot 1 .
Orange Book products# Current product rows page 1 of 1 · 1 matching rows.
Application-product, Trade name, Ingredient table Application-product Trade name Ingredient Strength Dosage form / route TE codes RLD / RS Approval date A091560-001 ABACAVIR SULFATE ABACAVIR SULFATE EQ 300MG BASE TABLET / ORAL AB RS 2013-09-13
Therapeutic equivalence codes# Current TE-code rows page 1 of 1 · 1 matching rows.
Application-product, TE code table Application-product TE code A091560-001 AB
Observed Orange Book product history# Observed FDA ZIP history: Each table is queried independently by exact application/product key from successfully parsed Orange Book snapshots. Capture times identify archived source observations; absence or a change between snapshots is not inferred. FDA publication files that were not recoverable as structured ZIP data are not represented as states.
Product history page 1 of 2 · 41 observed states.
Captured, Edition, Application-product table Captured Edition Application-product Trade name Strength Dosage form / route Product TE source text RLD / RS Approval date Source SHA-256 2026-02-19 14:30 UTC 2026-02 A091560-001 ABACAVIR SULFATE EQ 300MG BASE TABLET / ORAL AB RS 2013-09-13 011fe1cb6892…2025-12-14 10:44 UTC · 2 captures of this ZIP 2025-12 A091560-001 ABACAVIR SULFATE EQ 300MG BASE TABLET / ORAL AB RS 2013-09-13 31067a03dcf5…2025-08-23 18:47 UTC 2025-08 A091560-001 ABACAVIR SULFATE EQ 300MG BASE TABLET / ORAL AB RS 2013-09-13 6a471c1ec25d…2025-03-22 03:13 UTC · 3 captures of this ZIP 2025-03 A091560-001 ABACAVIR SULFATE EQ 300MG BASE TABLET / ORAL AB RS 2013-09-13 fd3edfee7708…2025-02-26 10:13 UTC · 3 captures of this ZIP 2025-02 A091560-001 ABACAVIR SULFATE EQ 300MG BASE TABLET / ORAL AB RS 2013-09-13 b8a1b40f171c…2025-01-19 17:59 UTC · 7 captures of this ZIP 2025-01 A091560-001 ABACAVIR SULFATE EQ 300MG BASE TABLET / ORAL AB RS 2013-09-13 03ed91905a0d…2024-12-13 21:23 UTC · 2 captures of this ZIP 2024-12 A091560-001 ABACAVIR SULFATE EQ 300MG BASE TABLET / ORAL AB RS 2013-09-13 2680178bc6a6…2024-09-14 05:58 UTC · 2 captures of this ZIP 2024-09 A091560-001 ABACAVIR SULFATE EQ 300MG BASE TABLET / ORAL AB RS 2013-09-13 5bbf6a4d5a75…2024-11-08 22:44 UTC · 3 captures of this ZIP 2024-11 A091560-001 ABACAVIR SULFATE EQ 300MG BASE TABLET / ORAL AB RS 2013-09-13 d8e5a09893c0…2024-10-29 15:01 UTC 2024-10 A091560-001 ABACAVIR SULFATE EQ 300MG BASE TABLET / ORAL AB RS 2013-09-13 d06236e962d9…2024-08-13 05:28 UTC · 3 captures of this ZIP 2024-08 A091560-001 ABACAVIR SULFATE EQ 300MG BASE TABLET / ORAL AB RS 2013-09-13 79d66fd596c7…2024-07-13 05:37 UTC · 2 captures of this ZIP 2024-07 A091560-001 ABACAVIR SULFATE EQ 300MG BASE TABLET / ORAL AB RS 2013-09-13 301d65b070ca…2024-06-18 03:08 UTC · 5 captures of this ZIP 2024-06 A091560-001 ABACAVIR SULFATE EQ 300MG BASE TABLET / ORAL AB RS 2013-09-13 1e350fbaab3a…2024-05-31 18:47 UTC 2024-05 A091560-001 ABACAVIR SULFATE EQ 300MG BASE TABLET / ORAL AB RS 2013-09-13 8072bd15b7f6…2022-06-29 02:47 UTC · 2 captures of this ZIP 2022-06 A091560-001 ABACAVIR SULFATE EQ 300MG BASE TABLET / ORAL AB 2013-09-13 5c6f7cd8ea54…2022-04-08 23:34 UTC 2022-04 A091560-001 ABACAVIR SULFATE EQ 300MG BASE TABLET / ORAL AB 2013-09-13 5d02ea3f76ae…2022-04-04 05:41 UTC 2022-04 A091560-001 ABACAVIR SULFATE EQ 300MG BASE TABLET / ORAL AB 2013-09-13 4b0b4de00fa7…2019-12-13 00:20 UTC 2019-12 A091560-001 ABACAVIR SULFATE EQ 300MG BASE TABLET / ORAL AB 2013-09-13 74a2ff9319b5…2022-03-09 01:35 UTC 2022-03 A091560-001 ABACAVIR SULFATE EQ 300MG BASE TABLET / ORAL AB 2013-09-13 bb7c543d1eb4…2021-12-28 21:50 UTC 2021-12 A091560-001 ABACAVIR SULFATE EQ 300MG BASE TABLET / ORAL AB 2013-09-13 782e0a99824c…2021-05-05 16:15 UTC · 3 captures of this ZIP 2021-05 A091560-001 ABACAVIR SULFATE EQ 300MG BASE TABLET / ORAL AB 2013-09-13 87673890dc5c…2021-03-12 10:30 UTC 2021-03 A091560-001 ABACAVIR SULFATE EQ 300MG BASE TABLET / ORAL AB 2013-09-13 5aa47cf7b7d7…2020-12-22 03:56 UTC 2020-12 A091560-001 ABACAVIR SULFATE EQ 300MG BASE TABLET / ORAL AB 2013-09-13 8869cabd3fbd…2020-11-12 02:37 UTC 2020-11 A091560-001 ABACAVIR SULFATE EQ 300MG BASE TABLET / ORAL AB 2013-09-13 c0c555d07b60…2019-12-14 00:12 UTC 2019-12 A091560-001 ABACAVIR SULFATE EQ 300MG BASE TABLET / ORAL AB 2013-09-13 3f01610625f2…2019-09-15 20:21 UTC 2019-09 A091560-001 ABACAVIR SULFATE EQ 300MG BASE TABLET / ORAL AB 2013-09-13 b00525d2431f…2019-07-19 19:46 UTC 2019-07 A091560-001 ABACAVIR SULFATE EQ 300MG BASE TABLET / ORAL AB 2013-09-13 ea99ee380514…2024-03-16 18:09 UTC · 4 captures of this ZIP 2024-03 A091560-001 ABACAVIR SULFATE EQ 300MG BASE TABLET / ORAL AB RS 2013-09-13 6a51e52b5d6a…2024-02-18 07:12 UTC 2024-02 A091560-001 ABACAVIR SULFATE EQ 300MG BASE TABLET / ORAL AB RS 2013-09-13 1c564ffb4f44…2023-12-20 04:57 UTC 2023-12 A091560-001 ABACAVIR SULFATE EQ 300MG BASE TABLET / ORAL AB 2013-09-13 ea1830bbd6c7…2023-11-28 05:40 UTC · 2 captures of this ZIP 2023-11 A091560-001 ABACAVIR SULFATE EQ 300MG BASE TABLET / ORAL AB 2013-09-13 a72a2bbeb626…2023-10-25 00:34 UTC · 2 captures of this ZIP 2023-10 A091560-001 ABACAVIR SULFATE EQ 300MG BASE TABLET / ORAL AB 2013-09-13 9b2671bbb829…2023-07-15 15:27 UTC · 2 captures of this ZIP 2023-07 A091560-001 ABACAVIR SULFATE EQ 300MG BASE TABLET / ORAL AB 2013-09-13 a67488948f0b…2023-06-13 01:57 UTC · 3 captures of this ZIP 2023-06 A091560-001 ABACAVIR SULFATE EQ 300MG BASE TABLET / ORAL AB 2013-09-13 3f0d92c62455…2023-05-13 08:27 UTC 2023-05 A091560-001 ABACAVIR SULFATE EQ 300MG BASE TABLET / ORAL AB 2013-09-13 053a50430f4f…2023-01-26 05:58 UTC 2023-01 A091560-001 ABACAVIR SULFATE EQ 300MG BASE TABLET / ORAL AB 2013-09-13 3bdfa0b2c4d7…2022-11-12 20:34 UTC · 5 captures of this ZIP 2022-11 A091560-001 ABACAVIR SULFATE EQ 300MG BASE TABLET / ORAL AB 2013-09-13 3a93d1ddd44b…2022-10-28 04:53 UTC 2022-10 A091560-001 ABACAVIR SULFATE EQ 300MG BASE TABLET / ORAL AB 2013-09-13 f41ea6bd6efb…2022-09-29 23:25 UTC 2022-09 A091560-001 ABACAVIR SULFATE EQ 300MG BASE TABLET / ORAL AB 2013-09-13 e64feba35796…2022-07-09 03:26 UTC · 3 captures of this ZIP 2022-07 A091560-001 ABACAVIR SULFATE EQ 300MG BASE TABLET / ORAL AB 2013-09-13 cb3db0bc1861…
Observed Orange Book normalized TE history# Normalized TE history page 1 of 2 · 41 observed states.
openFDA label cross-check# OpenFDA label data provides additional search and identifier links. DailyMed’s Structured Product Label is the canonical label on FDA.report. Matching records are deduplicated before they are shown below.
Matched openFDA labels page 1 of 1 · 4 matching rows.
Brand, Generic, Manufacturer table Brand Generic Manufacturer SPL set ID Effective date Available safety fields Join Abacavir ABACAVIR Camber Pharmaceuticals, Inc. 44fb1e25-ad03-4a7f-9f35-2e29f5025661 2026-07-04 Boxed warning, Warnings, Adverse reactions Exact identifier application applno (ANDA): 091560 application number: ANDA091560 ndc (product): 31722-557 Abacavir ABACAVIR Coupler LLC 42ca758a-1694-c614-e063-6294a90a8c7e 2026-01-19 Boxed warning, Warnings, Adverse reactions Exact identifier application applno (ANDA): 091560 application number: ANDA091560 Abacavir ABACAVIR AvPAK a2f06528-f3c5-2466-e053-2995a90ae18a 2026-01-08 Boxed warning, Warnings, Adverse reactions Exact identifier application applno (ANDA): 091560 application number: ANDA091560 Abacavir ABACAVIR XLCare Pharmaceuticals Inc. 633f1ec9-53b1-4a9a-a738-8cae5b763f08 2023-01-16 Boxed warning, Warnings, Adverse reactions Exact identifier application applno (ANDA): 091560 application number: ANDA091560
Additional Listing Data#
Finished product Yes
Brand name base Abacavir
Listing expiration 2027-12-31 Active Ingredients# Ingredient, Strength table Ingredient Strength ABACAVIR SULFATE 300 mg/1
Harmonized UNII identifiers# UNII identifiers page 1 of 1 · 1 matching rows.
Identifier, FDA.report destination table Identifier FDA.report destination J220T4J9Q2 Internal UNII lookup
Harmonized RxCUI identifiers# RxCUI identifiers page 1 of 1 · 1 matching rows.
Identifier, FDA.report destination table Identifier FDA.report destination 242679 Internal RxNorm lookup
Harmonized SPL set identifiers# SPL set identifiers page 1 of 1 · 1 matching rows.
DailyMed Product Concepts# DailyMed Package Descriptions# Package NDC, Product, Description table Package NDC Product Description Form Quantity Strength SPL version 31722-557-60 Abacavir 60 in 1 BOTTLE TABLET 60 6
DailyMed Socrata Ingredients# Ingredient, Type, UNII table Ingredient Type UNII DailyMed label SPL version Uploaded ABACAVIR SULFATE ACTIVE INGREDIENT J220T4J9Q2 ABACAVIR TABLET [CAMBER PHARMACEUTICALS, INC.] 2 ABACAVIR ACTIVE MOIETY WR2TIP26VS ABACAVIR TABLET [CAMBER PHARMACEUTICALS, INC.] 2 CELLULOSE, MICROCRYSTALLINE INACTIVE INGREDIENT OP1R32D61U ABACAVIR TABLET [CAMBER PHARMACEUTICALS, INC.] 2 COLLOIDAL SILICON DIOXIDE INACTIVE INGREDIENT ETJ7Z6XBU4 ABACAVIR TABLET [CAMBER PHARMACEUTICALS, INC.] 2 FERRIC OXIDE YELLOW INACTIVE INGREDIENT EX438O2MRT ABACAVIR TABLET [CAMBER PHARMACEUTICALS, INC.] 2 HYPROMELLOSES INACTIVE INGREDIENT 3NXW29V3WO ABACAVIR TABLET [CAMBER PHARMACEUTICALS, INC.] 2 MAGNESIUM STEARATE INACTIVE INGREDIENT 70097M6I30 ABACAVIR TABLET [CAMBER PHARMACEUTICALS, INC.] 2 POLYSORBATE 80 INACTIVE INGREDIENT 6OZP39ZG8H ABACAVIR TABLET [CAMBER PHARMACEUTICALS, INC.] 2 SODIUM STARCH GLYCOLATE TYPE A POTATO INACTIVE INGREDIENT 5856J3G2A2 ABACAVIR TABLET [CAMBER PHARMACEUTICALS, INC.] 2 TITANIUM DIOXIDE INACTIVE INGREDIENT 15FIX9V2JP ABACAVIR TABLET [CAMBER PHARMACEUTICALS, INC.] 2 TRIACETIN INACTIVE INGREDIENT XHX3C3X673 ABACAVIR TABLET [CAMBER PHARMACEUTICALS, INC.] 2
DailyMed Dashboard NDC Coverage# NDC, Dashboard title, SPL version table NDC Dashboard title SPL version Validation Dashboard ZIP 31722-557 ABACAVIR (ABACAVIR) TABLET [CAMBER PHARMACEUTICALS, INC.] 6 Current NDC, Legacy NDC, 1 package rows 20250112_44fb1e25-ad03-4a7f-9f35-2e29f5025661.zip
DailyMed RxNorm Mappings# Packages# Package NDC, 11-digit format, Description table Package NDC 11-digit format Description Units Marketing start Marketing end Sample Exclude flag Status 31722-557-60 31722055760 60 TABLET in 1 BOTTLE (31722-557-60) 60 tablet 2021-04-01 0000-00-00 No No Current